High Galectin-1 levels measured by gene expression profiling correlated with worse outcome in multiple myeloma, and knockdown of Galectin-1 in multiple myeloma cells resulted in smaller tumor formation and less lytic bone damage in an intra-tibeal injection model [10]. Here, LGALS1 is linked to AL amyloidosis.